NOVONESIS A/S NAM. B DK 2
NOVONESIS A/S NAM. B DK 2/ DK0060336014 /
NZM2
2024-04-26 3:41:04 PM
|
Chg.
+0.44
|
Volume |
Bid3:54:10 PM |
Ask3:54:10 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
52.24EUR
|
+0.85%
|
0 Turnover: 0.00 |
52.12Bid Size: 1,470 |
52.76Ask Size: 1,400 |
14.56 bill.EUR |
- |
- |
Business description
Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
Management board & Supervisory board
CEO |
Ester Baiget |
Management board |
Rainer Lehmann, Amy Byrick, Anders Lund, Claus Crone Fuglsang, Graziela Chaluppe dos Santos Malucelli, Morten Enggaard Rasmussen, Tina Sejersgård Fanø |
Supervisory board |
Cees de Jong, Andreas Hentze Knudsen, Anne Breum, Cees de Jong, Heine Dalsgaard, Jens Øbro, Kasim Kutay, Kim Stratton, Mathias Uhlén, Preben Nielsen, Sharon James |
Company data
Name: |
Novozymes A.S |
Address: |
Krogshoejvej 36,DK-2880 Bagsvaerd |
Phone: |
+45-44-460000 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.novozymes.com/ |
Industry: |
Biotechnology |
Sector: |
Biotechnology |
Sub sector: |
Biotechnology |
End of financial year: |
12-31 |
Free Float: |
74.50% |
IPO date: |
2000-11-20 |
Company calendar
CW 18 | 2024-04-30
General Shareholder Meeting
|
CW 18 | 2024-05-01
Ex-Dividend
|
CW 18 | 2024-05-03
Interim Report 1st Quarter/3 Months
|
CW 18 | 2024-05-03
Dividend Payment
|
CW 35 | 2024-08-28
Interim Report 2nd Quarter/6 Months
|